05.08.08
Pilot Study to Assess Safety and Efficacy of Medidur FA IN AMD Patients Treated with Lucentis

ATLANTA, May 8, 2008 -- Alimera Sciences Inc., a privately held ophthalmic pharmaceutical company announced today that enrollment has begun for a pilot study to assess the safety and efficacy of Medidur FA in conjunction with Lucentis® (ranibizumab injection, Genentech) in patients with exudative age-related macular degeneration (wet AMD).


05.07.08
CNN.com, Mixx Enter Alliance to Bolster Online News Community

Press Release
MCLEAN, Va.--(BUSINESS WIRE)--CNN and Mixx, a branded social news community, have entered an online content and co-marketing alliance to provide consumers with a seamless way to add CNN.com headlines and stories to their own personal blend of online news, information, photos and videos on Mixx.


05.01.08
6th Sense Analytics and Journyx Partner to Automate Time Tracking

CarolinaNewswire
MORRISVILLE, N.C. -- 6th Sense Analytics, Inc. and Journyx have partnered to deliver an automated time tracking solution. The integrated solution populates Journyx Timesheet™ with activity data automatically collected by 6th Sense Analytics.


04.28.08
New venture funds point Argos to a development crossroads

Fierce Biotech
Last week, Argos Therapeutics took a $35 million step toward its goal of generating proof-of-concept data. And after its first new venture round in six years, the developer was also able to see its next act start to come more clearly into focus.


04.24.08
Biotech firm gets $35 million

News & Observer
A Durham biotech company that is developing products to help boost patients' immune systems has picked up $35.2 million in new funding.

04.24.08
Aldagen Rounds Up $18M Insider Funding

Dow Jones VentureWire
Biopharmaceutical company Aldagen Inc. has raised an $18.4 million private funding round through inside investors Intersouth Partners, Tullis-Dickerson, Harbert Venture Partners and Aurora Funds.


04.24.08
Biolex Therapeutics Researchers Present Locteron(R) Phase 2a Hepatitis C Trial Results at EASL Conference

Press Release
PITTSBORO, NC- April 24, 2008) - Biolex Therapeutics, Inc. announced that the results from its SELECT-1 Phase 2a clinical trial of Locteron® will be presented today at the 43rd Annual Meeting of the European Association for the Study of the Liver (EASL).

04.23.08
Argos Pursues Phase II Data With $35M

Dow Jones VentureWire
Biopharmaceutical company Argos Therapeutics Inc. has closed a $35.2 million Series C round with the goal of obtaining positive Phase II results for its renal cell carcinoma- and HIV-targeted treatments.



04.22.08
SciQuest Selected as a Finalist in the 2008 Red Herring 100 North America

Press Release
CARY, N.C. -- SciQuest, Inc., the global leader in helping academic, healthcare and research-centric organizations realize the potential of strategic procurement, today announced that the company has been named a finalist for the Red Herring 100 Award, recognizing the 100 most innovative private technology companies based in North America.


04.21.08
TapRoot Systems Announces Free Trial Version of WalkingHotSpot™

Press Release
RESEARCH TRIANGLE PARK, N.C. -- TapRoot Systems Inc., a leading developer of software for the smartphone market, today announced that it is providing free trial versions of its WalkingHotSpot™ solution to Wi-Fi enabled smartphone users.



04.17.08
Coserics announces company formation including spin-out of phase 2 clinical asset from Serenex

Press Release
Durham, NC, April 17, 2008 – Coserics, LLC today announced its formation following a successful spin-out from Serenex, Inc. The new company commences operations with a clinical stage compound, SNX-1012, that is in phase 2 testing for treatment of chemotherapy induced oral mucositis in solid tumor patients.


04.16.08
6th Sense Analytics Announces Integration with Atlassian's JIRA

CarolinaNewswire
Morrisville, NC – 6th Sense Analytics Inc., provider of unbiased data and metrics into the status of outsourced software development projects, today announced its integration with Atlassian’s JIRA product, a bug tracking, issue tracking, and project management application.

04.16.08
Aldagen Announces Initiation of ALD-101 Phase III Trial for Improving Cord Blood Transplants in Pediatric Patients with Inherited Metabolic Diseases

Press Release
Durham, NC – April 16, 2008 – Aldagen, Inc. today announced that the first patient has been treated in a Phase III clinical trial for ALD-101. Aldagen is developing ALD-101 to improve cord blood transplants used to treat inherited metabolic diseases in pediatric patients. ALD-101 is a population of adult stem cells isolated from cord blood using Aldagen’s proprietary technology. The company commenced the Phase III clinical trial of ALD-101 to evaluate its ability to accelerate neutrophil and platelet engraftment following cord blood transplantation in these patients.


04.09.08
CallMiner and Aspect Software Awarded Contract by Daimler Financial Services Americas to Improve Contact Center Operations

Press Release
CallMiner, the leader in advanced speech analytics, and the PerformanceEdge Group of Aspect Software, the world's largest company focused solely on unified communications for the contact center, have been chosen by Daimler Financial Services Americas to monitor the quality, content, context, intention and outcome of contact center conversations.

04.08.08
Overture Networks Announces US Patent for Multipoint Protected Switching Ring

Press Release
RESEARCH TRIANGLE PARK, N.C. — Overture Networks, a leading developer of converged packet access solutions for Carrier Ethernet, today announced that it has been awarded US Patent # 7,339,887 for its Multipoint Protected Switching Ring.

04.02.08
SciQuest Announces 40% Year-Over-Year Revenue Growth

Press Release
CARY, N.C. – SciQuest, Inc., the global leader in helping organizations realize the potential of strategic procurement, announced that the company’s revenues for 2007 increased by 40 percent over fiscal year 2006.

03.31.08
Argos Therapeutics Presents Positive Phase 1 Safety Data for its Arcelis™ Platform in HIV at Keystone Symposia

CarolinaNewswire
DURHAM, N.C. -- Argos Therapeutics today announced the presentation of positive safety and feasibility data from a Phase 1 clinical trial of AGS-004 in HIV-infected adults in combination with antiretroviral therapy (ART).

03.26.08
TapRoot Turns Smartphones Into Hotspots

PC Magazine
If you're carrying a Windows Mobile device, you're probably carrying high-speed Internet around with you. With its new "Walking HotSpot" software, TapRoot Systems wants to liberate that Internet to connect PCs and whatever other Wi-Fi devices you have around.


03.24.08
DSMB Again Supports Continuation of The Phase III Clinical Trial of Medidur™ FA for the Treatment of DME

Press Release
After completing its review of safety and efficacy data currently available, an independent Data Safety Monitoring Board (DSMB) has once again recommended that the two pivotal Phase III clinical trials, known collectively as the FAME™ (Fluocinolone Acetonide in Diabetic Macular Edema) Study can continue under the current protocol, without change.

03.19.08
Alimera Raises $29M Series C

Dow Jones VentureWire
Seeking to strengthen its bid to go public later this year or early next, Alimera Sciences Inc. has raised a $28.5 million Series C round to acquire a majority stake in a diabetic macular-edema drug that it was developing with a partner.


03.18.08
Biolex Announces Presentation of Preclinical Results for Clot Buster BLX-155 at SIR Annual Scientific Meeting

Press Release
PITTSBORO, NC--(Marketwire - March 18, 2008) - Biolex Therapeutics, Inc. announced today that researchers presented results at the 33rd Annual Scientific Meeting of the Society of Interventional Radiology (SIR) in Washington, D.C. demonstrating that the thrombolytic activity of the Company's full-length recombinant plasmin (BLX-155) was superior to t-PA in a preclinical study.

03.18.08
Dan Traub of SciQuest Named a 2008 'Pro to Know' by Supply & Demand Chain Executive

CarolinaNewswire
CARY, N.C. -- SciQuest, Inc., the global leader in helping academic, healthcare and research-centric organizations realize the potential of strategic procurement, today announced that Dan Traub, lead solution engineer for the company, has been selected as a 2008 "Provider Pro to Know" by Supply & Demand Chain Executive magazine. Traub is featured in the magazine's February/March 2008 issue.


03.17.08
Alimera Sciences, pSivida Limited Amend Medidur™ FA Collaboration Agreement

Press Release
ATLANTA / BOSTON, March 17, 2008 - Alimera Sciences and pSivida Ltd (NASDAQ:PSDV, ASX:PSD, Xetra:PSI) today announced that they have amended their license and collaboration agreement relating to Medidur™ FA.

03.14.08
Proteon Thera Adds Gregory Phelps To Board

Dow Jones VentureWire
Proteon Therapeutics Inc., a developer of drugs to address kidney and vascular diseases, has appointed Gregory Phelps to the company's board of directors.


03.12.08
Proteon Therapeutics Receives European Patent

Press Release
WALTHAM, MA, and KANSAS CITY, MO (March 11, 2008) — Proteon Therapeutics, Inc., announced today that a key patent has been issued by the European Patent Office.

03.12.08
Biolex Announces Publication of Phase 1 Locteron(R) Results in the Journal of Interferon & Cytokine Research

Press Release
PITTSBORO, NC--(Marketwire - March 12, 2008) - Biolex Therapeutics, Inc. today announced the publication of results of a Phase 1 clinical trial of Locteron®, a controlled-release interferon alfa in development for the treatment of chronic hepatitis C, in the Journal of Interferon & Cytokine Research.

03.10.08
Argolyn Bioscience Grows Management Team

Press Release
CHARLESTON, SC and RESEARCH TRIANGLE PARK, NC – March 10, 2008 – Argolyn Bioscience Inc., a biotechnology company developing novel drugs to treat psychosis, pain and other disorders, today announced that it has expanded its management team with the addition of two key leaders.

03.05.08
State invests in open-source software firm Zenoss Inc.

Baltimore Business Journal
Maryland's economic development office is investing $250,000 in Zenoss Inc., an Annapolis software company that recently landed $11 million in venture capital.


03.04.08
Pfizer Picks Up Seven-Year-Old Serenex

Dow Jones VentureWire
Pfizer Inc., in a continued effort to reinvigorate its drug pipeline, has agreed to acquire cancer treatment developer Serenex Inc., a seven-year-old company that raised $81 million in equity over its life.



03.04.08
Aldagen Snags 27-Year J&J Exec As Finance Chief

Dow Jones VentureWire
Aldagen Inc., a biotechnology company advancing a pipeline of clinical-stage regenerative therapies, has hired David P. Carberry as chief financial officer.


03.03.08
Pfizer to Acquire Serenex to Extend Oncology Pipeline and Access Novel Technology Platform

Press Release
Pfizer Inc today announced that it has entered into an agreement to acquire Serenex, Inc., a privately-held biotechnology company with a Phase I clinical candidate and an extensive compound library that targets Heat Shock Protein 90 (Hsp90), an exciting target in the fight against cancer.

02.28.08
Serenex Announces Collaboration With National Cancer Institute to Initiate Clinical Trial With Serenex's Proprietary Small Molecule HSP90 Inhibitor, SNX-5422

Press Release
DURHAM, NC--(Marketwire - February 27, 2008) - Serenex, Inc., a leader in the discovery and development of small molecule Heat Shock Protein 90 (Hsp90) inhibitors, today announced the signing of a Clinical Trial Agreement (CTA) with the Center for Cancer Research (CCR) at the National Cancer Institute (NCI).

02.21.08
SciQuest Eprocurement to Advance Clemson University's Goal to Become a Top- Tier Research University

CarolinaNewswire
CARY, N.C. -- SciQuest, Inc., the global leader in helping academic and research-centric organizations realize the potential of strategic procurement, today announced that Clemson University has selected SciQuest's full suite of eprocurement solutions as the foundation for its entire source-to-settle procurement process.

02.19.08
Biolex Therapeutics Enters Into Agreement With Merck KGaA for Antibody Optimization

Press Release
Biolex Therapeutics today announced that it has entered into an agreement with Merck KGaA, Darmstadt to evaluate antibody optimization and production in Biolex's proprietary LEX System(SM).

02.15.08
Photonics Co. Gemfire Acquires Covega

Dow Jones VentureWire
Integrated photonics company Gemfire Corp. has announced the completion of an acquisition of Covega Corp., a developer of optical devices and modules.


02.13.08
Semprius Awarded $900K DOE SAI Program

Press Release
U.S. Department of Energy (DOE) Secretary Samuel W. Bodman today announced that the Department will invest $21.7 million in next generation photovoltaic (PV) technology to help accelerate the widespread use of advanced solar power, including a $900,000 grant to Semprius.



02.13.08
New Procedure Could Help Heart Patients

WRAL-TV
First Health Moore Regional Hospital is using nContact's solution to treat heart patients.

02.07.08
Biolex Therapeutics Commences United States Phase 2a Trial of Locteron(R) in Hepatitis C

Press Release
Biolex Therapeutics, Inc. today announced the commencement of patient dosing in a United States Phase 2a clinical trial of its lead product candidate Locteron for the treatment of hepatitis C.

02.01.08
Athenix and Syngenta in R&D Partnership for Advanced Biotechnology Corn Insect and Soybean Nematode Control Traits

CarolinaNewswire
Athenix Corp. announced today that it has entered into an agreement with Syngenta for the discovery of novel corn insect and soybean cyst nematode resistance genes.

02.01.08
SciQuest Brings a Distinguished Group of Eprocurement Visionaries and Professionals Together

CarolinaNewswire.com
SciQuest, Inc., one of the world’s fastest-growing providers of technology that automates the procurement and supplier management function and frees organizations to realize the full potential of a strategic approach to purchasing, today unveiled the presenter roster for its annual NextLevel executive conference.

01.31.08
Cempra Takes In $10M For Second Antibacterial Trial

VentureWire
Cempra Pharmaceuticals Inc., a company developing anti-infective drugs, has raised $10 million in Series B financing, the company's chief executive said.



01.28.08
So Many, Many Words

Wall Street Journal (subscription required)
Companies have a treasure trove of customer intelligence. Now they also have the tools from companies like Clarabridge to make sense of it.


01.24.08
Serenex Announces Collaboration With National Cancer Institute to Evaluate Proprietary Small Molecule Hsp90 Inhibitors as a Potential Treatment for Lung Cancer

Press Release
Serenex, Inc., a leader in the discovery and development of small molecule Heat Shock Protein 90 (Hsp90) inhibitors, today announced the signing of a Materials Cooperative Research and Development Agreement (M-CRADA) with the National Cancer Institute (NCI) at the National Institutes of Health (NIH).

01.24.08
Multiple Myeloma Research Foundation (MMRF) Grants $3.5 Million in Biotech Investment Awards

Press Release
NORWALK, Conn., Jan. 23, 2008 (PRIME NEWSWIRE) -- The Multiple Myeloma Research Foundation (MMRF) today announced that it has awarded a $1.5 million grant to Serenex, Inc.

01.23.08
Aldagen to Present at Leerink Swann and Wachovia Healthcare Conferences

Press Release
Durham, NC – January 23, 2008 – Aldagen, Inc., a biotechnology company advancing a pipeline of clinical-stage regenerative therapies, today announced that W. Thomas Amick, Chairman and CEO of Aldagen will be presenting at two upcoming investor conferences

01.22.08
Cellular South Introduces Location Based Services with LOC-AID Technologies

Press Release
Jackson, Miss. (January 22, 2008) – Cellular South has added another application to its line of products and services for business and government customers from LOC-AID Technologies.

01.21.08
Clarabridge - the Fastest-growing Text Analytics Software Company - Records Year of Surging Sales, Industry Accolades and Corporate Expansion

Press Release
Reston, Va. (January 21, 2008)—Clarabridge, a leading text analytics software company, today announced that it tripled its number of customers and grew revenues by 500 percent in 2007, making it the fastest-growing company in its market space.


01.21.08
Zenoss Achieves 500,000 Download Milestone and Announces

Press Release
Annapolis, MD -- January 22, 2007 – Zenoss, Inc., the leading commercial open source network and systems management software provider, today announced the achievement of a series of key company milestones including an $11 million round of financing, 500,000 downloads of its flagship product and a tenfold annual increase in its commercial customer base.

01.14.08
Durham's Nitronex raises $7.5 million

News & Observer
Nitronex, a Durham semiconductor company, has received $7.5 million in new funding.

01.11.08
Cempra gets $10M infusion; total investments top $30M

Triangle Business Journal
Triangle drug developer Cempra Pharmaceuticals has reached to the West Coast to snare an additional investor in a new financing round that will put $10 million into the company's war chest.

01.11.08
NovaMin sees breakout year for tooth renewing products

TechJournal South
ALACHUA, FL—NovaMin, one of the presenting companies at the second annual Southeastern Venture Conference Feb. 27-28 at Tysons Corner, Virginia, sees 2008 as “a breakout year,” for its tooth renewing technology, which has been called “the most important discovery for dental hygiene since fluoride.”


12.28.07
Trinity Convergence Gets $12.65M For VoIP

News Story
Trinity Convergence Inc., a provider of software for VoIP services, has raised $12.65 million in a Series D equity and debt financing.



12.18.07
Aldagen Appoints Laurence Keller, MD as Chief Medical Officer

Press Release
Durham, NC – December 18, 2007 – Aldagen, Inc., a biotechnology company advancing a pipeline of clinical-stage regenerative therapies, today announced that Laurence Keller, MD has been appointed as Chief Medical Officer (CMO).

12.12.07
Location-Based Services May Be Ready To Monetize

Dow Jones VentureWire
A new term floating around mobile technology circles is "mapvertising," which is the ability to purchase advertising inventory based on the advertiser's location.



12.11.07
Aldagen’s Adult Stem Cell Populations Shown to Regenerate Vascular Function and Repair Liver Damage

Press Release
Durham, NC – December 11, 2007 – Aldagen, Inc. today announced that researchers presented results demonstrating that the potent adult stem cell ppopulation isolated using Aldagen’s technology (ALDHbr cells) is able to regenerate vascular function and repair liver damage in preclinical models.

12.10.07
Biolex Researchers Present Results of Anti-CD20 Antibody With Optimized Glycosylation at ASH Conference

Press Release
PITTSBORO, NC - (December 10, 2007) - Biolex Therapeutics today announced that preclinical results of an anti-CD20 antibody optimized in its proprietary LEX System(SM) were presented yesterday at the 49th Annual Meeting of the American Society of Hematology (ASH) in Atlanta, Georgia.

12.06.07
SciQuest Appoints Ralph Mazza as Vice President of Global Professional Services

Press Release
CARY, N.C. -- SciQuest, Inc., the global leader in helping academic and research-centric organizations realize the potential of strategic procurement, today announced the appointment of Ralph Mazza as vice president of global professional services.

11.28.07
Integrian refocuses

Forbes
WASHINGTON, D.C. - In early 2004, Peter Durand took the top job at Integrian, a North Carolina company specializing in mobile surveillance systems for vehicles like police cars and buses. It's been a busy run since, with two venture funding rounds closed, three acquisitions, and a headcount that went from 12 to 200.

11.19.07
Aldagen to Present at 19th Annual Piper Jaffray Health Care Conference

Press Release
Durham, NC – November 19, 2007 – Aldagen, Inc., a biotechnology company advancing a pipeline of clinical-stage regenerative therapies, today announced that W. Thomas Amick, Chairman and CEO of Aldagen will be presenting at the 19th Annual Piper Jaffray Health Care Conference taking place from November 27-29 in New York, NY. During the presentation, Mr. Amick will provide an overview of the company including recent clinical and strategic developments.


11.16.07
Aldagen Adds Joel Kimbrough To Board

Dow Jones VentureWire
Aldagen Inc., a biotechnology company advancing a pipeline of clinical-stage regenerative therapies, has added Joel R. Kimbrough to its board of directors.

11.16.07
Argos Therapeutics and Therakos, Inc. Enter Exclusive Agreement for Regulatory T Cell Technology

Press Release
DURHAM, N.C. -- Argos Therapeutics has granted Therakos, Inc., a Johnson & Johnson company, an exclusive license for the research and development of novel treatments based on regulatory T cell technology developed by Argos. Terms of the agreement were not disclosed.


11.13.07
Web 2.0: Hype or Reality?

Triangle Business Journal
A new breed of tech companies are playing off faster broadband Internet speeds to offer online social and business networking tools. Featured clockwise are Triangle Web 2.0 enthusiasts, Red Hat’s Lee Congdon, Near-Time’s Reid Conrad, Intersouth Partners’ Mitch Mumma and Ryan Allis of iContact.


11.12.07
Semprius Awarded $900K DOE SAI Program

Press Release
Secretary Samuel W. Bodman today announced that the Department will invest $21.7 million in next generation photovoltaic (PV) technology to help accelerate the widespread use of advanced solar power.

11.12.07
Nitronex's 5W GAN on SI RF Power Transistor for Volume Production

Press Release
Durham, N.C. (November 12, 2007) — Nitronex, the global leader in gallium nitride on silicon (GaN on Si) RF power transistors for the wireless infrastructure, broadband and military markets, has developed a 28V, 5W class high electron mobility transistor (HEMT) designed for broadband applications.


11.07.07
Sentillion's solution stacks up

SearchServerVirtualization.com
If more companies used virtual desktop technologies, there would be a lot fewer news stories about stolen corporate laptops.


11.06.07
Trinity Convergence Announces Partnership with A.I.Corporation of Japan to Target IP Multimedia Device Market

Press Release
TOKYO & Research Triangle Park, NC - November 6, 2007 - Trinity Convergence, a leading provider of software solutions for IP communications devices, today announced it has established a partnership with A.I.Corporation (AIC) of Japan, a leading distributor of embedded software solutions.

11.06.07
Nitronex Qualifies New Wafer Fab for Volume Production

Press Release
Durham, N.C. (November 6, 2007) — Nitronex, the global leader in gallium nitride on silicon (GaN on Si) RF power transistors for the wireless infrastructure, broadband and military markets, has qualified its new, state-of-the-art manufacturing facility.

11.06.07
Biolex Therapeutics Researchers Present Locteron(TM) Phase 2a Hepatitis C Trial Results at AASLD Conference

Press Release
PITTSBORO, NC--(Marketwire - November 06, 2007) - Biolex Therapeutics, Inc. today announced that the results from its SELECT-1 Phase 2a clinical trial of Locteron™ will be presented today at the 58th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD).

11.01.07
Argos Therapeutics Presents Positive Data on its Personalized Cancer Immunotherapy Programs at ISTBC Meeting

Press Release
DURHAM, N.C. – November 1, 2007 – Argos Therapeutics today announced the presentation of two abstracts related to its personalized dendritic cell-based immunotherapy programs at the 22nd Annual Meeting of the International Society for the Biological Treatment of Cancer (iSTBc), held November 2-4 in Boston.

10.31.07
CallMiner and Clarabridge Align to Enhance Business Intelligence Garnered From Customer Communications

Press Release
FORT MYERS, FL and RESTON, VA, October 30 / MARKET WIRE/ -- CallMiner, a leading developer of advanced speech analytics software, and Clarabridge, a leading text analysis software company, today announced a partnership to offer companies complete insight into their customers' verbal and written communications to improve customer retention and satisfaction.


10.12.07
Biolex Therapeutics' LocteronTM Phase 2a Hepatitis C Trial Results Selected for Presentation at AASLD Conference

Press Release
Biolex Therapeutics today announced that the results from its SELECT-1 Phase 2a clinical trial of Locteron™ have been selected for presentation at the 58th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Boston on November 6, 2007.

10.12.07
Overture Networks to Present and Exhibit at Light Reading’s Ethernet Expo 2007

Press Release
Overture Networks, a leading developer of converged packet access platforms for Carrier Ethernet services, today announced that CEO Jeff Reedy will present at Light Reading’s Ethernet Expo at 10 a.m., October 16th in New York.

10.11.07
Mixx-ing Up the News: Virginia Startup Backed by Intersouth Changes Name

WRAL LocalTechWire
A startup company that received a seed investment from Intersouth Partners earlier this year emerged from stealth mode this week with a new name and focus.


10.08.07
Enrollment Complete In Pivotal Phase 3 Trial of Medidur™ FA for Diabetic Macular Edema

Press Release
Alimera Sciences Inc., a privately held ophthalmic pharmaceutical company, and pSivida Limited (NASDAQ:PSDV, ASX:PSD, Xetra:PSI), announced today that enrollment is complete for the FAME™ (Fluocinolone Acetonide in Diabetic Macular Edema) Study of Medidur™ FA for the treatment of Diabetic Macular Edema.

10.05.07
Ziptronix Names New President & CEO

Press Release
Morrisville, N.C. – October 5, 2007 – Ziptronix, Inc., a leader in developing next-generation three-dimensional semiconductor integration strategies and processes, today announced that Kenneth L. Donahue has joined the company as President and CEO.


10.02.07
Nitronex Expands Agreement with Richardson Electronics To Include Americas and Asia

Press Release
Nitronex, an innovative developer and manufacturer of high-performance GaN on Si RF power transistors for the commercial and broadband wireless infrastructure markets, has expanded its partnership with Richardson Electronics to include distribution in the Americas and all of Asia.

09.27.07
Overture gets $12 million for Europe, new products

News & Observer
Overture Networks secured $12.3 million in venture capital that the seven-year-old Morrisville telecommunications company plans to use to hire more sales reps and compete for customers in Europe.


09.26.07
Nitronex’s GaN-on-Si Broadband Doherty Power Amplifier Enhances Efficiency and Bandwidth for WiMAX Applications

Press Release
Nitronex, an innovative developer and manufacturer of high-performance RF power transistors for the commercial and broadband wireless infrastructure markets, has partnered with Prescient Wireless to design a GaN-on-Si broadband Doherty power amplifier for WiMAX applications.

09.24.07
Innovation Awards: Where Are They Now?

Wall Street Journal
The Journal's past Innovation Awards winners, including Semprius, have been busy lately. Here's a look at the progress some have made .

09.17.07
Intersouth again invests in Proteon

Triangle Business Journal
Durham's Intersouth Partners has pumped more cash into Proteon Therapeutics, a Waltham, Mass., company developing drugs for kidney and blood diseases.

09.10.07
Alimera Sciences Signs Agreement with Emory University

Press Release
Alimera Sciences will enter into an exclusive worldwide agreement with Emory University to explore oxidative stress management -- specifically the reduction of reactive oxygen species (ROS) -- as a treatment for ophthalmic diseases.


09.03.07
In N.C., A Second Industrial Revolution; Biotech Surge Shows Manufacturing Still Key to U.S. Economy

Washington Post
The hosiery mill is gone now, along with much of the Carolina textile industry -- a casualty of the global reordering that has concentrated production in Asia and Latin America. But the old brick building is still here and still making products. Today, the site is occupied by a biotechnology company, Biolex Therapeutics.

08.27.07
Software Can Speed and Simplify the Provisioning of IT Users

Computerworld
Since BryanLGH began deploying Sentillion Inc.’s Provisioning Manager application in 2005, it has dramatically cut the time needed to equip new employees with accounts and passwords. The system has also helped the hospital comply with the Health Insurance Portability and Accountability Act by providing reports and an auditable, consistent process for assigning access to patient data.


08.14.07
6th Sense Analytics Provides Free Public Access To Developer Community Data

Carolina NewsWire
6th Sense Analytics, Inc., a pioneer in automating software development metrics, today announced the availability of a free public resource for understanding trends in the software development community, based on data collected from the 6th Sense Analytics user community.

08.06.07
Integrian, Inc., Launches Public Safety Solutions in Australia

Press Release
Integrian, Inc. a leading provider of advanced mobile surveillance solutions is pleased to announce the launch of its DigitalPatroller® DP-2 system in Australia.

08.02.07
New patrol car cameras to hit streets

Midland Reporter-Telegram
Midland, Texas officials say a new camera, referred to as a DP2, will allow better surveillance and a 60-hour recording time, whereas the cameras in use now only have a 40-hour recording time. "We have eight or nine in now, so the DP2s should be operational within the next two weeks," said Traffic Sgt. Rick Lewis.


08.01.07
Bausch & Lomb Acquires Soothe® Emollient (Lubricant) Eye Drops from Alimera Sciences; Expands Product Line

Press Release
Bausch & Lomb (NYSE: BOL) today announced its acquisition of Soothe emollient (lubricant) eye drops from Alimera Sciences, a privately-held ophthalmic pharmaceutical company.

07.31.07
Biolex Therapeutics Announces Positive Phase 2a Results for Hepatitis C Product Candidate Locteron

Press Release
Biolex Therapeutics today announced successful initial results from the SELECT-1 Phase 2a clinical trial of Locteron, the first controlled-release interferon alfa being developed for the treatment of chronic hepatitis C.

07.24.07
Demand for DigitalPatroller DP-2 Continues to Rise

Press Release
Since launching at the IACP show in Boston last October, demand for Integrian’s DigitalPatroller DP-2 has continued to climb.

07.13.07
Biolex Therapeutics Presents Preclinical Results for Clot Buster BLX-155 at the International Society on Thrombosis and Haemostasis Meeting

Press Release
Biolex Therapeutics announced today that Company researchers have presented results at the XXIst Congress of The International Society on Thrombosis and Haemostasis (ISTH) in Geneva, Switzerland demonstrating that full-length recombinant plasmin (BLX-155) produced with the Company's proprietary LEX System(SM) is indistinguishable from human plasma-derived plasmin in characterization and activity.

07.10.07
Aldagen Adds Three Clinical Sites to its Critical Limb Ischemia Study

Press Release
Aldagen, today announced the addition of three new sites for its clinical trial of ALD-301 for the treatment of critical limb ischemia. The three additional sites are Duke University Medical Center (Durham, NC), Indiana University (Indianapolis, IN) and Saint Joseph’s Research Institute (Atlanta, GA).

07.02.07
Aldagen Establishes New Manufacturing Facility

Press Release
Aldagen, Inc., a biotechnology company advancing a pipeline of clinical-stage regenerative therapies, today announced it has established a Class 10,000 clean room for Good Manufacturing Practice (GMP)-certified manufacture of its cellular products.

06.28.07
Durham’s Serenex lands $31M

TechJournal South
Serenex Inc., which is developing treatments for cancer and other illnesses, has raised a $31 million financing that includes four new investors.

06.25.07
Argolyn Bioscience Raises $15.8M in Financing

LocalTechWire
Argolyn Biosciences, a spinout from the Medical University of South Carolina, has closed on $15.8 million in financing. Intersouth Partners, which is based in Durham, N.C., and Quaker BioVentures led the round.


06.25.07
SC's Argolyn Bioscience lands $15.8M first round

TechJournal South
Argolyn Bioscience Inc., which is developing treatments for psychosis, pain and other disorders, has raised a $15.8 million first round co-led by Intersouth Partners and Quaker BioVentures. Amgen Ventures also participated in what is one of the largest biotech deals in SC history.


06.22.07
Semprius: printing a new future for semiconductors

TechJournal South
On the heels of winning the NC Council for Entrepreneurial Development’s “Spin-out” of the year award, Semprius Inc. landed a $100,000 Small Business Innovation Grant this week for its semiconductor printing technology.


06.20.07
Video: Doctor Develops Procedure to Help Regulate Heartbeats

WRAL
A new procedure developed at FirstHealth Moore Regional Hospital called the Ex Maze procedure is a less invasive way to get the heart permanently back in rhythm. This video features nContact's device to treat atrial fibrillation.


06.20.07
Athenix and Monsanto announce collaboration on research for insect control

Press Release
Athenix Corp. and Monsanto Company today announced they have entered into a three-year research collaboration for insect control on a key class of insects that affects a number of Monsanto's major crops of interest.

06.07.07
Durham biotech Viamet raises $4 million

News & Observer
Viamet Pharmaceuticals, an early-stage biotechnology company, has raised $4 million in venture capital financing. The Durham company was founded in 2005 and is run by CEO Robert Schotzinger. Viamet is developing treatments for cancer and other diseases with compounds designed to help the body more effectively use metal ions such as zinc and iron.

06.07.07
Viamet Pharmaceuticals Raises $4 Million Round of Financing

Press Release
Viamet Pharmaceuticals Inc., a biotechnology company targeting metalloenzymes in the fields of infectious disease, inflammation and oncology, announced today that it has closed a $4 million Series A financing round.


06.05.07
Overture Networks provides Telekenex Managed Ethernet Deployment

Carolina Newswire
Overture Networks, a leading developer of converged packet access solutions, today announced that Telekenex, a business-grade IP service provider, has selected its solutions for reliable and cost-effective managed Ethernet service deployment including business quality voice, video and data services.

06.05.07
NC’s Encelle acquired by Pioneer Surgical

TechJournal South
Michigan-based Pioneer Surgical Technology has acquired Raleigh-based Encelle, a tissue regeneration company. Terms of the deal were not disclosed.

05.30.07
Reston's Clarabridge learns from competition and customers

TechJournal South
When Clarabridge's founders spun off the company from the successful data warehousing consulting company Claraview in late 2005, they knew there would be lessons to learn.

05.29.07
Alachua oral hygiene company wants to get in your toothpaste

The Gainesville Sun
NovaMin Technology Inc. is talking with 35 companies around the world, including most of the major brands of toothpaste, and it hopes the ingredient will become the next standard in a $30 billion industry.


05.25.07
Growing Interest in Biolex Produces Oversubscribed $30M Round

LocalTechWire
Biolex Therapeutics has closed on $30 million in Series C venture financing. The round was oversubscribed, meaning investors put more money into the firm than management had intended to raise.


05.24.07
Nitronex Names Director of RF Product Development

Press Release
Nitronex, an innovative developer and manufacturer of high-performance RF power transistors for the commercial and broadband wireless infrastructure markets, has named Doru Roll as Director of RF Product Development.

05.24.07
Aldagen Expands Board of Directors

Press Release
Aldagen, Inc., a biotechnology company advancing a pipeline of clinical-stage regenerative therapies, today announced the appointment of Dr. Martin J. Murphy,
Jr. to its Board of Directors.

05.24.07
TapRoot Systems, Inc. Supports Windows Mobile for Beceem Communications WiMAX Chipsets

Press Release
TapRoot Systems Inc., a leading provider of embedded software solutions and reference platforms for smartphones, today announced a collaboration with Beceem Communications (www.beceem.com), the leading mobile WiMAX chipset provider, to support Windows Mobile 6.0 on Beceem’s mobile WiMAX chipset.

05.11.07
Serenex targets new capital

Triangle Business Journal
As it awaits a go-ahead from federal regulators to begin human trials on a second cancer drug, Serenex is closing in on a fourth round funding.

[ Show archived stories ]